Wilke HJ - Search Results

1

High-dose ara-C and etoposide in refractory or relapsing acute leukemia.

Freund M, Link H, Diedrich H, LeBlanc S, Wilke HJ, Poliwoda H. Freund M, et al. Among authors: wilke hj. Cancer Chemother Pharmacol. 1991;28(6):487-90. doi: 10.1007/BF00685829. Cancer Chemother Pharmacol. 1991. PMID: 1934254

2

A phase II study of high dose tamoxifen in progressive, metastatic renal cell carcinoma.

Stahl M, Wilke H, Schmoll HJ, Schöber C, Diedrich H, Casper J, Freund M, Poliwoda H. Stahl M, et al. Among authors: wilke h. Ann Oncol. 1992 Feb;3(2):167-8. doi: 10.1093/oxfordjournals.annonc.a058136. Ann Oncol. 1992. PMID: 1606089 Free article. Clinical Trial.

3

Mitoxantrone, cytosine arabinoside, and VP-16 in 36 patients with relapsed and refractory acute myeloid leukemia.

Link H, Freund M, Diedrich H, Wilke H, Austein J, Henke M, Wandt H, Fackler-Schwalbe E, Schlimok G, Hoffmann R, et al. Link H, et al. Haematol Blood Transfus. 1990;33:322-5. doi: 10.1007/978-3-642-74643-7_60. Haematol Blood Transfus. 1990. PMID: 2182426 Clinical Trial.

4

A 3-day schedule of 5-fluorouracil and folinic acid in metastatic progressive colorectal cancer and its impact in terms of palliation.

Schöber C, Köhne-Wömpner CH, Schmoll HJ, Stahl M, Wilke HJ, Poliwoda H. Schöber C, et al. Among authors: wilke hj. Semin Oncol. 1992 Apr;19(2 Suppl 3):136-40. Semin Oncol. 1992. PMID: 1557639 Clinical Trial.

5

Treatment with natural human interferon alpha of a CML-patient with antibodies to recombinant interferon alpha-2b.

Freund M, von Wussow P, Knüver-Hopf J, Mohr H, Pohl U, Exeriede G, Link H, Wilke HJ, Poliwoda H. Freund M, et al. Among authors: wilke hj. Blut. 1988 Nov;57(5):311-5. doi: 10.1007/BF00320360. Blut. 1988. PMID: 3196882

6

Modulation of cytotoxic drug activity by dipyridamole.

Schmoll HJ, Harstrick A, Köhne-Wömpner CH, Schöber C, Wilke H, Poliwoda H. Schmoll HJ, et al. Among authors: wilke h. Cancer Treat Rev. 1990 Dec;17 Suppl A:57-65. doi: 10.1016/0305-7372(90)90017-a. Cancer Treat Rev. 1990. PMID: 2092872 Review. No abstract available.

7

High dose epirubicin in refractory or relapsed non-seminomatous testicular cancer: a phase II study.

Harstrick A, Schmoll HJ, Wilke H, Schöber C, Stahl M, Wömpner CK, Bokemeyer C, Dölken G, Burk K, Poliwoda H. Harstrick A, et al. Among authors: wilke h. Ann Oncol. 1990 Sep;1(5):375-6. doi: 10.1093/oxfordjournals.annonc.a057778. Ann Oncol. 1990. PMID: 2261377 Free article. Clinical Trial.

8

High dose folinic acid/etoposide/5-fluorouracil in advanced gastric cancer--a phase II study in elderly patients or patients with cardiac risk.

Wilke H, Preusser P, Fink U, Achterrath W, Lenaz L, Stahl M, Schober C, Link H, Meyer HJ, Lucke B, et al. Wilke H, et al. Invest New Drugs. 1990 Feb;8(1):65-70. doi: 10.1007/BF00216926. Invest New Drugs. 1990. PMID: 2345071

9

Comparison of the antitumor activity of cisplatin, carboplatin, and iproplatin against established human testicular cancer cell lines in vivo and in vitro.

Harstrick A, Casper J, Guba R, Wilke H, Poliwoda H, Schmoll HJ. Harstrick A, et al. Among authors: wilke h. Cancer. 1989 Mar 15;63(6):1079-83. doi: 10.1002/1097-0142(19890315)63:6<1079::aid-cncr2820630607>3.0.co;2-j. Cancer. 1989. PMID: 2645036

10

Recombinant human interferon (IFN) alpha-2b in chronic myelogenous leukaemia: dose dependency of response and frequency of neutralizing anti-interferon antibodies.

Freund M, von Wussow P, Diedrich H, Eisert R, Link H, Wilke H, Buchholz F, LeBlanc S, Fonatsch C, Deicher H, et al. Freund M, et al. Br J Haematol. 1989 Jul;72(3):350-6. doi: 10.1111/j.1365-2141.1989.tb07715.x. Br J Haematol. 1989. PMID: 2765403

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

404 results

Search Page

Filters